465 related articles for article (PubMed ID: 24401666)
1. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic significance of coagulation assays in melanoma.
Tas F; Ciftci R; Kilic L; Bilgin E; Keskin S; Sen F; Yildiz I; Yasasever V
Melanoma Res; 2012 Oct; 22(5):368-75. PubMed ID: 22889867
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic significance of coagulation assays in gastric cancer.
Tas F; Ciftci R; Kilic L; Serilmez M; Karabulut S; Duranyildiz D
J Gastrointest Cancer; 2013 Sep; 44(3):285-92. PubMed ID: 23536321
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma.
Tas F; Karabulut S; Bilgin E; Kılıc L; Ciftci R; Duranyildiz D
J Gastrointest Cancer; 2013 Dec; 44(4):404-9. PubMed ID: 23765155
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of coagulation assays in lung cancer.
Tas F; Kilic L; Serilmez M; Keskin S; Sen F; Duranyildiz D
Respir Med; 2013 Mar; 107(3):451-7. PubMed ID: 23200643
[TBL] [Abstract][Full Text] [Related]
7. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of D-dimer in lung cancer.
İnal T; Anar C; Polat G; Ünsal İ; Halilçolar H
Clin Respir J; 2015 Jul; 9(3):305-13. PubMed ID: 24720709
[TBL] [Abstract][Full Text] [Related]
9. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
10. Very high concentration of D-dimers in portal blood in patients with pancreatic cancer.
Durczyński A; Szymański D; Nowicki M; Hogendorf P; Poznańska G; Strzelczyk J
Pol Przegl Chir; 2012 Oct; 84(10):521-5. PubMed ID: 23324368
[TBL] [Abstract][Full Text] [Related]
11. Research on the coagulation function changes in non small cell lung cancer patients and analysis of their correlation with metastasis and survival.
Qi Y; Fu J
J BUON; 2017; 22(2):462-467. PubMed ID: 28534370
[TBL] [Abstract][Full Text] [Related]
12. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
Jianlong M; Diansheng Z; Jing R
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
[TBL] [Abstract][Full Text] [Related]
13. The effect of whole-body cooling on hematological and coagulation parameters in asphyxic newborns.
Oncel MY; Erdeve O; Calisici E; Oguz SS; Canpolat FE; Uras N; Dilmen U
Pediatr Hematol Oncol; 2013 Apr; 30(3):246-52. PubMed ID: 23445486
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
15. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
Zhang D; Hao J; Yang N
J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
[TBL] [Abstract][Full Text] [Related]
16. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.
Ricci G; Cerneca F; Simeone R; Pozzobon C; Guarnieri S; Sartore A; Pregazzi R; Guaschino S
Hum Reprod; 2004 Apr; 19(4):838-48. PubMed ID: 15016779
[TBL] [Abstract][Full Text] [Related]
17. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.
Onguru P; Dagdas S; Bodur H; Yilmaz M; Akinci E; Eren S; Ozet G
J Clin Lab Anal; 2010; 24(3):163-6. PubMed ID: 20486197
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
20. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
Zhang PP; Sun JW; Wang XY; Liu XM; Li K
Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
